Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony Meager

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Immunological Methods|February 28, 2002
Biological assays for interferonsAnthony Meager
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Assays for cytotoxicityAnthony Meager
Methods (San Diego, Calif.)|February 17, 2006
Measurement of cytokines by bioassays: theory and applicationAnthony Meager
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Assays for antiviral activityAnthony Meager
Biologicals : Journal of the International Association of Biological Standardization|September 30, 2004
Seventh WHO informal consultation on standards for cytokines, growth factors and endocrinological substancesAnthony Meager
Expert Review of Clinical Immunology|June 6, 2014
Detection of anti-cytokine antibodies and their clinical relevanceAnthony Meager, Meenu Wadhwa
Journal of Immunological Methods|October 18, 2005
Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon betaAnthony Meager, Rose Gaines Das
Journal of Immunological Methods|July 9, 2013
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samplesIsabelle Cludts, Anthony Meager, Robin Thorpe, et al.
Cytokine|February 2, 2010
Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assayIsabelle Cludts, Anthony Meager, Robin Thorpe, et al.
Science (New York, N.Y.)|September 16, 2021
Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Kai Kisand, Anthony Meager, Adrian Hayday, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Immunological Methods|February 28, 2002
Biological assays for interferonsAnthony Meager
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Assays for cytotoxicityAnthony Meager
Methods (San Diego, Calif.)|February 17, 2006
Measurement of cytokines by bioassays: theory and applicationAnthony Meager
Methods in Molecular Biology (Clifton, N.J.)|October 24, 2003
Assays for antiviral activityAnthony Meager
Biologicals : Journal of the International Association of Biological Standardization|September 30, 2004
Seventh WHO informal consultation on standards for cytokines, growth factors and endocrinological substancesAnthony Meager
Expert Review of Clinical Immunology|June 6, 2014
Detection of anti-cytokine antibodies and their clinical relevanceAnthony Meager, Meenu Wadhwa
Journal of Immunological Methods|October 18, 2005
Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon betaAnthony Meager, Rose Gaines Das
Journal of Immunological Methods|July 9, 2013
Development and characterization of a non-cell-based assay to assess the presence of neutralizing antibodies to interferon-beta in clinical samplesIsabelle Cludts, Anthony Meager, Robin Thorpe, et al.
Cytokine|February 2, 2010
Detection of neutralizing interleukin-17 antibodies in autoimmune polyendocrinopathy syndrome-1 (APS-1) patients using a novel non-cell based electrochemiluminescence assayIsabelle Cludts, Anthony Meager, Robin Thorpe, et al.
Science (New York, N.Y.)|September 16, 2021
Comment on "Aberrant type 1 immunity drives susceptibility to mucosal fungal infections"Kai Kisand, Anthony Meager, Adrian Hayday, et al.
Pageof 4